2.37

1.66% -0.04

After Hours: 2.38 0.010 +0.42%

BioAffinity Technologies Inc (BIAF)

Overview News Price History Discussions Forecast

BioAffinity Technologies Inc stock is currently priced at $2.37, with a 24-hour trading volume of 94,848. It has seen a -1.66% decreased in the last 24 hours and a +13.40% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $2.44 pivot point. If it approaches the $2.28 support level, significant changes may occur.

Previous Close:

$2.41

Open:

$2.32

24h Volume:

94,848

Market Cap:

$27.29M

Revenue:

$321.50K

Net Income/Loss:

$-7.24M

P/E Ratio:

-1.3544

EPS:

-1.7498

Net Cash Flow:

$-5.72M

1W Performance:

-14.75%

1M Performance:

+13.40%

6M Performance:

+59.06%

1Y Performance:

+16.18%

1D Range:

$2.32

$2.4299

52W Range:

$0.9548

$3.62

BioAffinity Technologies Inc Stock (BIAF) Company Profile

Name

BioAffinity Technologies Inc

Sector

Healthcare (1191)

Industry

Diagnostics & Research (66)

Phone

210 698 5334

Address

22211 West Interstate 10, Suite 1206, San Antonio

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BIAF's Discussions on Twitter

BioAffinity Technologies Inc Stock (BIAF) Latest News

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views

Benzinga

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

BioAffinity Technologies Inc Stock (BIAF) Financials Data

BioAffinity Technologies Inc (BIAF) Revenue 2024

BIAF reported a revenue (TTM) of $321.50 thousand for the quarter ending September 30, 2023.

BioAffinity Technologies Inc (BIAF) Net Income 2024

BIAF net income (TTM) was -$7.24 million for the quarter ending September 30, 2023, a +39.96% increase year-over-year.

BioAffinity Technologies Inc (BIAF) Cash Flow 2024

BIAF recorded a free cash flow (TTM) of -$5.72 million for the quarter ending September 30, 2023, a -67.19% decrease year-over-year.

BioAffinity Technologies Inc (BIAF) Earnings per Share 2024

BIAF earnings per share (TTM) was -$0.8398 for the quarter ending September 30, 2023, a +77.82% growth year-over-year.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.